Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2006 Aug;50(8):2829-32.
doi: 10.1128/AAC.00524-06.

Killing kinetics of caspofungin, micafungin, and amphotericin B against Candida guilliermondii

Affiliations
Comparative Study

Killing kinetics of caspofungin, micafungin, and amphotericin B against Candida guilliermondii

Emilia Cantón et al. Antimicrob Agents Chemother. 2006 Aug.

Abstract

Amphotericin B (AMB), micafungin, and caspofungin MICs, minimal fungicidal concentrations, and time-killing curves were determined in the presence and absence of 10% inactivated serum. AMB was the only agent with consistent killing activity (time required to achieve 99.9% of growth reduction was 2.1 to 3.2 h). The presence of serum enhanced caspofungin activity but lowered those of micafungin and AMB.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Time-killing kinetics assays of AMB, micafungin, and caspofungin against C. guilliermondii. Average datum points and standard deviations are provided for eight C. guilliermondii isolates. Upper panels, RPMI medium. Lower panels, RPMI plus 10% inactivated FBS. A, amphotericin B; B, micafungin; C, caspofungin.
FIG. 2.
FIG. 2.
Relationship of amphotericin B, caspofungin, and micafungin concentrations and K values (regression lines) of survival time for C. guilliermondii in the presence (continuous line) or absence (dotted line) of inactivated fetal (10%) bovine serum. For caspofungin and micafungin, regression lines are practically horizontal (with and without serum) and almost identical (lines overlap).

Similar articles

Cited by

References

    1. Ainbinder, D. J., V. C. Parmley, T. H. Mader, and M. L. Nelson. 1998. Infectious crystalline keratopathy caused by Candida guilliermondii. Am. J. Ophthalmol. 125:723-725. - PubMed
    1. Barry, A. L., M. A. Pfaller, S. D. Brown, A. Espinel-Ingroff, M. A. Ghannoum, C. Knapp, R. P. Rennie, J. H. Rex, and M. G. Rinaldi. 2000. Quality control limits for broth microdilution susceptibility tests of ten antifungal agents. J. Clin. Microbiol. 38:3457-3459. - PMC - PubMed
    1. Bartizal, K., C. J. Gill, G. K. Abruzzo, A. M. Flattery, L. Kong, P. M. Scott, J. G. Smith, C. E. Leighton, A. Bouffard, J. F. Dropinski, and J. Balkovec. 1997. In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872). Antimicrob. Agents Chemother. 41:2326-2332. - PMC - PubMed
    1. Cantón, E., J. Pemán, A. Viudes, G. Quindós, M. Gobernado, and A. Espinel-Ingroff. 2003. Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species. Diagn. Microbiol. Infect. Dis. 45:203-206. - PubMed
    1. Cantón, E., J. Pemán, M. Gobernado, A. Viudes, and A. Espinel-Ingroff. 2004. Patterns of AMB killing against seven Candida species. Antimicrob. Agents Chemother. 48:2477-2482. - PMC - PubMed

Publication types

LinkOut - more resources